Retrospective analysis of 2870 patients with invasive carcinoma of the cervix treated by radiotherapy from 1971 to 1978 showed that the prognosis for younger patients (defined as either under 35 or under 40) was better than that for older age groups, but young patients presented with earlier disease. When the effect of stage on prognosis -was also considered the improved survival of patients under 35 was confirmed, although the result was of only borderline significance. The better survival of younger patients was particularly noticeable for stage IB disease, the corrected five year survival ofthose under 35 being 93% compared with 79% for those over 35.
Introduction
The incidence of carcinoma of the cervix has increased among younger patients. Among women aged 25- 1) showed that younger patients had a better prognosis, the result being highly significant (p=0-0001 or less). Proportionately more young patients, however, presented at the earlier stages, and survival was therefore considered within each stage. Table I When the data were considered for all patients by age and allowing for stage the result was of borderline significance (X2=3-29, df= 1, p=0 0695) when stratification was by those under and over 35, but it reached significance when stratification was into more age bands (overall X2=7 98, df=3, p=005; X2 for trend=4-65, df=l, p=003). Again the oldest age group had a poorer survival while the prognosis in the three other age bands was about equal. Table II shows the relative risk of death in the under 35 age group compared with those 35 and over, together with 95% confidence intervals, in each stage (except for stage IA) and overall. The observed risk of death in the younger age group was 20% less than that in the older age group. The results were compatible with a true risk of death ranging from a reduction of 37% to an increase of 1%'in the younger age group compared with the older group.
Discussion
In this study patients aged under 35 with carcinoma of the cervix treated by radical radiotherapy had a better overall prognosis than older patients, but a higher proportion of young patients presented with earlier stage tumours. When the effect of stage was considered younger patients still fared better than women over 35, although this result was of only borderline significance. The main factor affecting the prognosis of women under 35 was the survival of those with stage IB disease. The treatment techniques used within each stage were basically similar over the whole age range except that a few elderly patients and any patient in generally poor health had a less radical form of management.
The possibility that a more aggressive, rapidly progressive tumour occurs in younger patients has been suggested, excluded in an earlier series from the Johns Hopkins Hospital, also i and Herman in a smaller series from New York did not confirm that age is of prognostic importance,20 nor did van Voorhis in a series of 762 patients from Iowa.21 An early series in which radium alone was used failed to find any prognostic value in age.' 9 Series in which both surgery and radiotherapy have been given have not found age a significant factor in prognosis, 22-24 and indeed Gynning et al noted a different effect of age when two different treatment techniques were used for stage IB tumours (radical radiotherapy alone, bothl intracavity and external beam, or radical radiotherapy followed by elective hysterectomy).29 Other radiotherapy series have found that the effect of age on survival varies with stage.30 '1 These divergent and potentially confusing findings must result, at least in part, from the effect ofother prognostic factors. Age alone does not adequately indicate prognosis even when the effect of stage is also considered. In this study there was no evidence that young patients with cervical cancer treated by radical radiotherapy during the 1970s had a more aggressive form ofmalignancy. In most stages ofdisease their prognosis was similar to that ofolder patients, and in stage IB it was considerably better. We therefore conclude that younger age alone is not an indication for adjuvant treatment for cervical cancer.
